ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Qingling Zhang
Matched on ORCID iD 0000-0002-5287-264X; OpenAlex author ID A5100704869. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2025.06.020↗
- Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer. Co-author DOI 10.1038/s41421-024-00720-w↗
- COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction. Last author DOI 10.3389/fonc.2022.1049345↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Huiheng Ning · 1 shared paper, 2025 · strength 0.21
- Lusheng Wei · 1 shared paper, 2025 · strength 0.21
- Kang Chen · 1 shared paper, 2025 · strength 0.21
- Minmin Chen · 1 shared paper, 2025 · strength 0.21
- Min Yu · 1 shared paper, 2025 · strength 0.21
- Zemin Zhang · 1 shared paper, 2025 · strength 0.21
- Dingwen Zhang · 1 shared paper, 2025 · strength 0.21
- Rufu Chen · 1 shared paper, 2025 · strength 0.21
- Zhihui Wen · 1 shared paper, 2022 · strength 0.16
- Rosa F. Hwang · 1 shared paper, 2024 · strength 0.14
- Yohei Saito · 1 shared paper, 2024 · strength 0.14
- Yongkun Wei · 1 shared paper, 2024 · strength 0.14
- Huamin Wang · 1 shared paper, 2024 · strength 0.14
- Jun Yao · 1 shared paper, 2024 · strength 0.14
- Haoqiang Ying · 1 shared paper, 2024 · strength 0.14
- Ronald Anthony Depinho · 1 shared paper, 2024 · strength 0.14
- Paul J. Chiao · 1 shared paper, 2024 · strength 0.14
- Dihua Yu · 1 shared paper, 2024 · strength 0.14
- Anirban Maitra · 1 shared paper, 2024 · strength 0.14
- Mien‐Chie Hung · 1 shared paper, 2024 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.